TNFSF13B Antilichaam - N-terminalgebied: FITC (ARP58542 P050-FITC)

Tumor necrosis factor (ligand) superfamily, member 13b

DTL, BAFF, BLYS, CD257, TALL1, THANK, ZTNF4, TALL-1, TNLG7A, TNFSF20

10673

Q9Y275

NP_006564

Human, Horse

The immunogen is a synthetic peptide directed towards the N terminal region of human TNFSF13B

The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This cytokine is a ligand for receptors TNFRSF13B/TACI, TNFRSF17/BCMA, and TNFRSF13C/BAFFR. This cytokine is expressed in B cell lineage cells, a

TNFRSF13C; TNFRSF13B; TNFSF12; APP; TNFSF13; TNFSF13B; TNFRSF17

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

Affinity Purified

0.5 mg/ml

Horse: 83%; Human: 100%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

31kDa

Xing, X.W., (2003) Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 35 (3), 283-288

Wet Ice

285

TNFSF13B

TNFSF13B

Rabbit

Tumor necrosis factor ligand superfamily member 13B

NM_080675

ALQGDLASLRAELQGHHAEKLPAGAGAPKAGLEEAPAVTAGLKIFEPPAP